Targeted Oncology (@targetedonc) 's Twitter Profile
Targeted Oncology

@targetedonc

Oncology news and insights from leading researchers and cancer centers.

ID: 726304448

linkhttp://targetedonc.com calendar_today30-07-2012 15:43:54

43,43K Tweet

20,20K Followers

3,3K Following

Targeted Oncology (@targetedonc) 's Twitter Profile Photo

The first patient has been dosed with mRNA-4106, a novel pantumor antigen therapy candidate, in a phase 1 trial for those with advanced or metastatic solid tumors. Amita Patnaik Moderna hubs.li/Q03n8fcj0